Organoid Model Predictive of Response to Immunotherapies

NCT06084676 · clinicaltrials.gov ↗

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped difficulty recruiting participants

Conditions

Breast Cancer

Interventions

DRUG: Immunotherapy

Sponsor

Indiana University